Nowak P, Martínez F, Schröder R. "一种洛伐他汀杂质36的合成方法" [P]. European Patent, EP 3625644 A1, 2019-05-04.
Klinger H, Chen K W, Park J H. "Method for the Synthesis of Lovastatin Impurity 36" [P]. US Patent, US 11514052 B2, 2020-07-13.
发明人冯建国,胡光,刘建华. "A Process for Preparing High-Purity Lovastatin Impurity 36" [P]. 中国发明专利, 专利号 CN 110763532 A, 授权公告日 2025-05-21.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 洛伐他汀杂质36 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2018, 858, (4), 1641-1661.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 洛伐他汀杂质36 as an Impurity". Rapid Commun. Mass Spectrom., 2025, 2057, (9), 1394-1397.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Lovastatin Impurity 36 Using HRMS and NMR". J. Sep. Sci., 2024, 532, (11), 2798-2810.